With binding to ESS sites in exon 12, hnRNP A1 increases exon 12 inclusion of ATP7B, that hnRNP A1 silencing promotes ATP7B exon12 exclusion, potentially attenuating the toxic effects of ATP7B exon 12 mutation in Wilson’s disease (Lin et al., 2015). This evidence concerns the gene ATP7B and Wilson disease.